Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Express Scripts
Medtronic
AstraZeneca
Boehringer Ingelheim

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Patent Applications for naldemedine tosylate


Email this page to a colleague

« Back to Dashboard

US Patent Applications for naldemedine tosylate

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Free Forever Trial ⤷  Free Forever Trial PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVES 2018-10-12 Response to Non-Final Office Action Entered and Forwarded to Examiner 2021-02-18
⤷  Free Forever Trial ⤷  Free Forever Trial 0000-00-00 0000-00-00
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Harvard Business School
Moodys
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.